Last reviewed · How we verify
Corticosteroid Eye Drop
Corticosteroid eye drops reduce inflammation in the eye by suppressing the immune system.
Corticosteroid eye drops reduce inflammation in the eye by suppressing the immune system. Used for Treatment of non-infectious uveitis affecting the posterior segment of the eye.
At a glance
| Generic name | Corticosteroid Eye Drop |
|---|---|
| Sponsor | Ocugen |
| Drug class | Corticosteroid |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | Phase 2 |
Mechanism of action
They do this by inhibiting the production of pro-inflammatory cytokines and other mediators of inflammation. This leads to a decrease in the number of inflammatory cells in the eye, which helps to reduce swelling and pain. Corticosteroids can also help to prevent scarring and promote healing in the eye.
Approved indications
- Treatment of non-infectious uveitis affecting the posterior segment of the eye
Common side effects
- Increased intraocular pressure
Key clinical trials
- Loteprednol Etabonate Versus Prednisolone Acetate for Anterior Chamber Granulomas (PHASE4)
- A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression (PHASE2)
- Dextenza Versus Topical Steroid Eye Drops for Postoperative Management Following Corneal Crosslinking (PHASE1, PHASE2)
- Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery (PHASE4)
- Dextenza in the Post-op Management of Vitreoretinal Surgeries (PHASE4)
- Parasitic Ulcer Treatment Trial (PHASE3)
- Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction II (PHASE3)
- The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Corticosteroid Eye Drop CI brief — competitive landscape report
- Corticosteroid Eye Drop updates RSS · CI watch RSS
- Ocugen portfolio CI